Home
>
National Drug Code (NDC)
>
Prevalite
Prevalite - 0245-0036-23 - (cholestyramine)
Drug Information of Prevalite
| Product NDC: | 0245-0036 |
| Proprietary Name: | Prevalite |
| Non Proprietary Name: | cholestyramine |
| Active Ingredient(s): | 4 g/5.5g & nbsp; cholestyramine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Prevalite
| Product NDC: | 0245-0036 |
| Labeler Name: | Upsher-Smith Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA073263 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19960201 |
Package Information of Prevalite
| Package NDC: | 0245-0036-23 |
| Package Description: | 231 g in 1 CAN (0245-0036-23) |
NDC Information of Prevalite
| NDC Code | 0245-0036-23 |
| Proprietary Name | Prevalite |
| Package Description | 231 g in 1 CAN (0245-0036-23) |
| Product NDC | 0245-0036 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cholestyramine |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 19960201 |
| Marketing Category Name | ANDA |
| Labeler Name | Upsher-Smith Laboratories Inc. |
| Substance Name | CHOLESTYRAMINE |
| Strength Number | 4 |
| Strength Unit | g/5.5g |
| Pharmaceutical Classes | Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] |
